{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T23:39:59Z","timestamp":1793317199339,"version":"4.5.0"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2023,5,19]],"date-time":"2023-05-19T00:00:00Z","timestamp":1684454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,5,19]],"date-time":"2023-05-19T00:00:00Z","timestamp":1684454400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Nephrol"],"published-print":{"date-parts":[[2023,11]]},"DOI":"10.1007\/s00467-023-05993-z","type":"journal-article","created":{"date-parts":[[2023,5,19]],"date-time":"2023-05-19T11:02:31Z","timestamp":1684494151000},"page":"3625-3633","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["COL4A gene variants are common in children with hematuria and a family history of kidney disease"],"prefix":"10.1007","volume":"38","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2494-3970","authenticated-orcid":false,"given":"Michelle N.","family":"Rheault","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heather M.","family":"McLaughlin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asia","family":"Mitchell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lauren E.","family":"Blake","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prasad","family":"Devarajan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bradley A.","family":"Warady","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keisha L.","family":"Gibson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth V.","family":"Lieberman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,5,19]]},"reference":[{"key":"5993_CR1","doi-asserted-by":"publisher","first-page":"1126","DOI":"10.1016\/j.kint.2022.03.019","volume":"101","author":"KDIGO Conference Participants","year":"2022","unstructured":"KDIGO Conference Participants (2022) Genetics in chronic kidney disease: conclusions from a kidney disease: improving global outcomes (KDIGO) controversies conference. Kidney Int 101:1126\u20131141. https:\/\/doi.org\/10.1016\/j.kint.2022.03.019","journal-title":"Kidney Int"},{"key":"5993_CR2","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1016\/j.kint.2018.02.027","volume":"94","author":"G Bullich","year":"2018","unstructured":"Bullich G, Domingo-Gallego A, Vargas I et al (2018) A kidney-disease gene panel allows a comprehensive genetic diagnosis of cystic and glomerular inherited kidney diseases. Kidney Int 94:363\u2013371. https:\/\/doi.org\/10.1016\/j.kint.2018.02.027","journal-title":"Kidney Int"},{"key":"5993_CR3","doi-asserted-by":"publisher","first-page":"1050","DOI":"10.1016\/j.xkme.2021.08.006","volume":"3","author":"M Mrug","year":"2021","unstructured":"Mrug M, Bloom MS, Seto C et al (2021) Genetic testing for chronic kidney diseases: clinical utility and barriers perceived by Nephrologists. Kidney Med 3:1050\u20131056. https:\/\/doi.org\/10.1016\/j.xkme.2021.08.006","journal-title":"Kidney Med"},{"key":"5993_CR4","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1016\/s0022-3476(79)80710-6","volume":"95","author":"VM Vehaskari","year":"1979","unstructured":"Vehaskari VM, Rapola J, Koskimies O, Savilahti E, Vilska J, Hallman N (1979) Microscopic hematuria in school children: epidemiology and clinicopathologic evaluation. J Pediatr 95:676\u2013684. https:\/\/doi.org\/10.1016\/s0022-3476(79)80710-6","journal-title":"J Pediatr"},{"key":"5993_CR5","doi-asserted-by":"publisher","unstructured":"Lieberman K, Chang A, Block G et al (2022) The KIDNEYCODE program: diagnostic yield and clinical features of individuals with chronic kidney disease. Kidney360 3:900\u2013909. https:\/\/doi.org\/10.34067\/KID.0004162021","DOI":"10.34067\/KID.0004162021"},{"key":"5993_CR6","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1056\/NEJMoa1806891","volume":"380","author":"EE Groopman","year":"2019","unstructured":"Groopman EE, Marasa M, Cameron-Christie S et al (2019) Diagnostic utility of exome sequencing for kidney disease. N Engl J Med 380:142\u2013151. https:\/\/doi.org\/10.1056\/NEJMoa1806891","journal-title":"N Engl J Med"},{"key":"5993_CR7","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1016\/j.kint.2017.12.018","volume":"93","author":"CE Kashtan","year":"2018","unstructured":"Kashtan CE, Ding J, Garosi G et al (2018) Alport syndrome: a unified classification of genetic disorders of collagen IV alpha345: a position paper of the Alport Syndrome Classification Working Group. Kidney Int 93:1045\u20131051. https:\/\/doi.org\/10.1016\/j.kint.2017.12.018","journal-title":"Kidney Int"},{"key":"5993_CR8","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1681\/ASN.V114649","volume":"11","author":"JP Jais","year":"2000","unstructured":"Jais JP, Knebelmann B, Giatras I et al (2000) X-linked Alport syndrome: natural history in 195 families and genotype- phenotype correlations in males. J Am Soc Nephrol 11:649\u2013657. https:\/\/doi.org\/10.1681\/ASN.V114649","journal-title":"J Am Soc Nephrol"},{"key":"5993_CR9","doi-asserted-by":"publisher","first-page":"1535","DOI":"10.1007\/s00467-014-2797-4","volume":"29","author":"M Oka","year":"2014","unstructured":"Oka M, Nozu K, Kaito H et al (2014) Natural history of genetically proven autosomal recessive Alport syndrome. Pediatr Nephrol 29:1535\u20131544","journal-title":"Pediatr Nephrol"},{"key":"5993_CR10","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1007\/s00467-014-2797-4","volume":"78","author":"M Furlano","year":"2021","unstructured":"Furlano M, Martinez V, Pybus M et al (2021) Clinical and genetic features of autosomal dominant Alport syndrome: a cohort study. Am J Kidney Dis 78:560-570.e1. https:\/\/doi.org\/10.1007\/s00467-014-2797-4","journal-title":"Am J Kidney Dis"},{"key":"5993_CR11","doi-asserted-by":"publisher","first-page":"1713","DOI":"10.2215\/CJN.00580116","volume":"11","author":"J Savige","year":"2016","unstructured":"Savige J, Colville D, Rheault M et al (2016) Alport syndrome in women and girls. Clin J Am Soc Nephrol 11:1713\u20131720. https:\/\/doi.org\/10.2215\/CJN.00580116","journal-title":"Clin J Am Soc Nephrol"},{"key":"5993_CR12","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1093\/ndt\/gfv325","volume":"31","author":"C Gast","year":"2016","unstructured":"Gast C, Pengelly RJ, Lyon M et al (2016) Collagen (COL4A) mutations are the most frequent mutations underlying adult focal segmental glomerulosclerosis. Nephrol Dial Transplant 31:961\u2013970. https:\/\/doi.org\/10.1093\/ndt\/gfv325","journal-title":"Nephrol Dial Transplant"},{"key":"5993_CR13","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.1038\/ki.2014.305","volume":"86","author":"AF Malone","year":"2014","unstructured":"Malone AF, Phelan PJ, Hall G et al (2014) Rare hereditary COL4A3\/COL4A4 variants may be mistaken for familial focal segmental glomerulosclerosis. Kidney Int 86:1253\u20131259. https:\/\/doi.org\/10.1038\/ki.2014.305","journal-title":"Kidney Int"},{"key":"5993_CR14","doi-asserted-by":"publisher","first-page":"2721","DOI":"10.1093\/ndt\/gfp158","volume":"24","author":"A Pierides","year":"2009","unstructured":"Pierides A, Voskarides K, Athanasiou Y et al (2009) Clinico-pathological correlations in 127 patients in 11 large pedigrees, segregating one of three heterozygous mutations in the COL4A3\/ COL4A4 genes associated with familial haematuria and significant late progression to proteinuria and chronic kidney disease from focal segmental glomerulosclerosis. Nephrol Dial Transplant 24:2721\u20132729. https:\/\/doi.org\/10.1093\/ndt\/gfp158","journal-title":"Nephrol Dial Transplant"},{"key":"5993_CR15","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1038\/ki.2011.407","volume":"81","author":"O Gross","year":"2012","unstructured":"Gross O, Licht C, Anders HJ et al (2012) Early angiotensin-converting enzyme inhibition in Alport syndrome delays renal failure and improves life expectancy. Kidney Int 81:494\u2013501. https:\/\/doi.org\/10.1038\/ki.2011.407","journal-title":"Kidney Int"},{"key":"5993_CR16","doi-asserted-by":"publisher","first-page":"1605","DOI":"10.1016\/j.kint.2020.06.038","volume":"98","author":"T Yamamura","year":"2020","unstructured":"Yamamura T, Horinouchi T, Nagano C et al (2020) Genotype-phenotype correlation and the influence of the genotype on response to angiotensin-targeting drugs in Japanese patients with male X-linked Alport syndrome. Kidney Int 98:1605\u20131614. https:\/\/doi.org\/10.1016\/j.kint.2020.06.038","journal-title":"Kidney Int"},{"key":"5993_CR17","doi-asserted-by":"publisher","first-page":"2719","DOI":"10.1007\/s00467-021-05040-9","volume":"36","author":"Y Zhang","year":"2021","unstructured":"Zhang Y, Bockhaus J, Wang F et al (2021) Genotype-phenotype correlations and nephroprotective effects of RAAS inhibition in patients with autosomal recessive Alport syndrome. Pediatr Nephrol 36:2719\u20132730. https:\/\/doi.org\/10.1007\/s00467-021-05040-9","journal-title":"Pediatr Nephrol"},{"key":"5993_CR18","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.1016\/j.kint.2019.12.015","volume":"97","author":"O Gross","year":"2020","unstructured":"Gross O, T\u00f6nshoff B, Weber LT et al (2020) A multicenter, randomized, placebo-controlled, double-blind phase 3 trial with open-arm comparison indicates safety and efficacy of nephroprotective therapy with ramipril in children with Alport\u2019s syndrome. Kidney Int 97:1275\u20131286. https:\/\/doi.org\/10.1016\/j.kint.2019.12.015","journal-title":"Kidney Int"},{"key":"5993_CR19","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1007\/s00467-020-04819-6","volume":"36","author":"CE Kashtan","year":"2021","unstructured":"Kashtan CE, Gross O (2021) Clinical practice recommendations for the diagnosis and management of Alport syndrome in children, adolescents, and young adults-an update for 2020. Pediatr Nephrol 36:711\u2013719. https:\/\/doi.org\/10.1007\/s00467-020-04819-6","journal-title":"Pediatr Nephrol"},{"key":"5993_CR20","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1093\/ndt\/gfz028","volume":"35","author":"DM Connaughton","year":"2020","unstructured":"Connaughton DM, Hildebrandt F (2020) Personalized medicine in chronic kidney disease by detection of monogenic mutations. Nephrol Dial Transplant 35:390\u2013397. https:\/\/doi.org\/10.1093\/ndt\/gfz028","journal-title":"Nephrol Dial Transplant"},{"key":"5993_CR21","doi-asserted-by":"publisher","first-page":"914","DOI":"10.1016\/j.kint.2018.10.031","volume":"95","author":"DM Connaughton","year":"2019","unstructured":"Connaughton DM, Kennedy C, Shril S et al (2019) Monogenic causes of chronic kidney disease in adults. Kidney Int 95:914\u2013928. https:\/\/doi.org\/10.1016\/j.kint.2018.10.031","journal-title":"Kidney Int"},{"key":"5993_CR22","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1016\/j.kint.2019.01.038","volume":"96","author":"I Ottlewski","year":"2019","unstructured":"Ottlewski I, M\u00fcnch J, Wagner T et al (2019) Value of renal gene panel diagnostics in adults waiting for kidney transplantation due to undetermined end-stage renal disease. Kidney Int 96:222\u2013230. https:\/\/doi.org\/10.1016\/j.kint.2019.01.038","journal-title":"Kidney Int"},{"key":"5993_CR23","doi-asserted-by":"publisher","first-page":"100","DOI":"10.7326\/M17-1319","volume":"168","author":"S Lata","year":"2018","unstructured":"Lata S, Marasa M, Li Y et al (2018) Whole-exome sequencing in adults with chronic kidney disease: a pilot study. Ann Intern Med 168:100\u2013109. https:\/\/doi.org\/10.7326\/M17-1319","journal-title":"Ann Intern Med"},{"key":"5993_CR24","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1038\/s41436-020-00963-4","volume":"23","author":"K Jayasinghe","year":"2021","unstructured":"Jayasinghe K, Stark Z, Kerr PG et al (2021) Clinical impact of genomic testing in patients with suspected monogenic kidney disease. Genet Med 23:183\u2013191. https:\/\/doi.org\/10.1038\/s41436-020-00963-4","journal-title":"Genet Med"},{"key":"5993_CR25","doi-asserted-by":"publisher","first-page":"2740","DOI":"10.1681\/ASN.2013080912","volume":"25","author":"V Morini\u00e8re","year":"2014","unstructured":"Morini\u00e8re V, Dahan K, Hilbert P et al (2014) Improving mutation screening in familial hematuric nephropathies through next generation sequencing. J Am Soc Nephrol 25:2740\u20132751. https:\/\/doi.org\/10.1681\/ASN.2013080912","journal-title":"J Am Soc Nephrol"},{"key":"5993_CR26","doi-asserted-by":"publisher","first-page":"2148","DOI":"10.34067\/KID.0002732022","volume":"3","author":"L Cirillo","year":"2022","unstructured":"Cirillo L, Becherucci F (2022) Genetic testing in nephrology: show your pedigree! Kidney360 3:2148\u20132152. https:\/\/doi.org\/10.34067\/KID.0002732022","journal-title":"Kidney360"}],"container-title":["Pediatric Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00467-023-05993-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00467-023-05993-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00467-023-05993-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,21]],"date-time":"2023-09-21T11:07:37Z","timestamp":1695294457000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00467-023-05993-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,19]]},"references-count":26,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2023,11]]}},"alternative-id":["5993"],"URL":"https:\/\/doi.org\/10.1007\/s00467-023-05993-z","relation":{},"ISSN":["0931-041X","1432-198X"],"issn-type":[{"value":"0931-041X","type":"print"},{"value":"1432-198X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,5,19]]},"assertion":[{"value":"20 December 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 March 2023","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 April 2023","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 May 2023","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"MNR is a site PI for Reata, Chinook, Travere, and Sanofi and a consultant for Visterra, Horizon, and ENYO Pharma. HMM, AM, and LB are current or former employees and stockholders of Invitae\u00ae Corporation. PD is on the medical advisory board for Alnylam, Dicerna, Reata, and Bioporto. BAW is a consultant for Reata, Bayer, Roche and Amgen. KG is a consultant for Travere, Aurinia, and Reata. KVL has received honoraria from Reata.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}